---

$238.54

+2.6250 ( +1.11% ) 63.4K

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2025-05-13	Buy	1680.00	Davis Todd C
2025-05-13	Buy	1000.00	Espinoza Octavio
2024-08-13	Sale	-18245.00	Korenberg Matthew E
2024-08-09	Buy	2500.00	Davis Todd C
2024-07-02	Sale	-350.00	Korenberg Matthew E
2024-07-02	Sale	-350.00	Davis Todd C
2024-07-02	Sale	-329.00	Reardon Andrew
2024-07-02	Sale	-267.00	Espinoza Octavio
2024-06-25	Sale	-1252.00	Sabba Stephen L
2024-06-18	Sale	-1252.00	Gray Nancy Ryan